Annual review of clinical research on extracorporeal life support in 2023
10.3760/cma.j.cn121430-20231204-01038
- VernacularTitle:2023年体外生命支持临床研究回顾
- Author:
Hongling ZHANG
1
;
Yuan YU
;
Dechang CHEN
;
You SHANG
Author Information
1. 华中科技大学同济医学院附属协和医院重症医学科，湖北武汉 430022
- Keywords:
Extracorporeal life support;
Veno-arterial extracorporeal membrane oxygenation;
Veno-venous extracorporeal membrane oxygenation;
Extracorporeal cardiopul
- From:
Chinese Critical Care Medicine
2024;36(2):118-123
- CountryChina
- Language:Chinese
-
Abstract:
The clinical research in the field of extracorporeal life support (ECLS) in 2023 has focused on the efficacy of veno-arterial extracorporeal membrane oxygenation (ECMO) in patients with infarct-related cardiogenic shock. Additionally, the research also explored the efficacy of prone positioning during veno-venous ECMO, transfusion strategies, and the impact of obesity on outcomes. Awake veno-venous ECMO has shown novel therapeutic potential, but its optimal practice methods and management strategies remain to be determined. In in-hospital cardiac arrest patients, extracorporeal cardiopulmonary resuscitation has demonstrated higher survival rates and better neurological recovery compared to conventional cardiopulmonary resuscitation. The effectiveness of extracorporeal carbon dioxide removal varies among patients with different types of respiratory failure. Future research should focus on optimizing the application strategies and process management of ECLS technologies, investigating personalized therapy, and studying how to improve long-term rehabilitation and quality of life for survivors.
